semaglutide dangerous FBI issues safety warning about counterfeit versions of weight loss drug The Alarming Surge in Compounded

And thats what makes GLP-1 screening so crucial

US modeling by Blue Cross Blue Shield suggests that broad GLP1 coverage could add measurable pressure to employer premiums over the next decade, depending on uptake and duration of therapy

Dispose of the used needle immediately in an FDA-cleared sharps container

The rise of GLP-1s for conditions like menopause highlights that weight and health are not one-size-fits-all, making personalization more important than ever

For comparison, Wegovy appears to have had just one ad running on Facebook this year before June

MHRA-approved options for weight management in the UK include semaglutide 2.4 mg (Wegovy), tirzepatide (Mounjaro), orlistat, and naltrexone/bupropion (Mysimba), with eligibility criteria varying by treatment